Credit Suisse Ag Wave Life Sciences Ltd. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Credit Suisse Ag holds 128,720 shares of WVE stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

128,720

Previous 111,931 15.0%

Holding current value

$1.49 Million

Previous $565,000 40.53%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.54 - $6.84 $59,433 - $114,836	16,789 Added 15.0%	128,720 $794,000
Q4 2023 Feb 08, 2024	BUY	$4.16 - $6.87 $465,632 - $768,965	111,931 New	111,931 $565,000
Q2 2022 Aug 12, 2022	BUY	$1.23 - $3.25 $29 - $78	24 New	24 $0
Q2 2021 Aug 16, 2021	SELL	$5.65 - $7.47 $131,452 - $173,797	-23,266 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.61 - $12.01 $43,101 - $92,272	-7,683 Reduced 24.82%	23,266 $130,000
Q4 2020 Feb 12, 2021	BUY	$6.99 - $9.26 $64,629 - $85,617	9,246 Added 42.6%	30,949 $244,000
Q3 2020 Nov 13, 2020	BUY	$8.49 - $19.54 $3,548 - $8,167	418 Added 1.96%	21,703 $184,000
Q2 2020 Aug 12, 2020	BUY	$7.44 - $11.29 $81,936 - $124,336	11,013 Added 107.21%	21,285 $221,000
Q1 2020 May 13, 2020	SELL	$6.94 - $14.22 $18,030 - $36,943	-2,598 Reduced 20.19%	10,272 $96,000
Q4 2019 Feb 12, 2020	SELL	$7.99 - $37.6 $10,283 - $48,391	-1,287 Reduced 9.09%	12,870 $103,000
Q3 2019 Nov 12, 2019	BUY	$19.17 - $27.4 $116,764 - $166,893	6,091 Added 75.51%	14,157 $291,000
Q2 2019 Aug 14, 2019	SELL	$22.93 - $42.84 $70,440 - $131,604	-3,072 Reduced 27.58%	8,066 $210,000
Q1 2019 May 14, 2019	BUY	$32.69 - $47.91 $87,445 - $128,159	2,675 Added 31.61%	11,138 $432,000
Q4 2018 Feb 13, 2019	BUY	$37.1 - $50.11 $61,252 - $82,731	1,651 Added 24.24%	8,463 $356,000
Q3 2018 Nov 13, 2018	SELL	$36.35 - $55.2 $66,011 - $100,243	-1,816 Reduced 21.05%	6,812 $341,000
Q2 2018 Aug 14, 2018	SELL	$33.85 - $50.65 $12,727 - $19,044	-376 Reduced 4.18%	8,628 $330,000
Q1 2018 May 15, 2018	BUY	$32.45 - $54.7 $29,010 - $48,901	894 Added 11.02%	9,004 $361,000
Q4 2017 Feb 14, 2018	SELL	$21.8 - $39.35 $74,338 - $134,183	-3,410 Reduced 29.6%	8,110 $284,000
Q3 2017 Nov 14, 2017	BUY	$16.4 - $25.05 $188,927 - $288,576	11,520	11,520 $251,000

Others Institutions Holding WVE

# of Institutions

171

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.01B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account